Lone Risperdal Defense Verdict for J&J Overturned
Shellers honored as National Liberty Museum’s “2017 Heroes of Liberty”
The National Liberty Museum honored Stephen and Sandra Sheller as “2017 Heroes of Liberty” at the 18th Annual Glass Auction & Gala held on October 7, 2017 at the Sheraton Philadelphia Downtown Hotel. The Shellers were recognized for their support of the Museum and the community through their nonprofit organizations The Sheller Family Foundation and […]
SCOTUS Ruling Increases Risperdal Suits in PA
Risperdal litigation in Philadelphia courts have increased significantly this year and the trend is likely to continue. Mass torts against Janssen, a Johnson & Johnson subsidiary, over it’s antipsychotic drug Risperdal has nearly tripled in Pennsylvania. Plaintiff attorneys say the biggest cause for the recent influx is the expiration of a tolling agreement between Janssen […]
Checkbook Science
In 1984 a federal jury in San Francisco found Dow Corning’s breast implants were “defectively designed and manufactured.” Maria Stern was awarded $1.7 M after internal corporate memos and studies show that Dow had failed to warn the public of the health risks associated with breast implants. Evidence from the case was sealed by the […]
The Chamber: ‘One More Bullet in J&J’s Gun’
In ‘For Plaintiffs Bar, Taking on J&J Means Battling a Shadow Foe,’ Law.com’s Amanda Bronstad reports on the “intimate relationship” between Johnson & Johnson (J&J) and the U.S. Chamber of Commerce (the Chamber). The U.S. Chamber of Commerce is not a government entity, but a powerful group of lobbyists, the largest in the nation. Plaintiff’s lawyers point out […]
Breast Implant Safety Controversy Fueled by Junk Science
A new type of lymphoma called breast implant-associated anapestic large-cell lymphoma has medical authorities finally agreeing that the prosthetics can cause disease. The first recognized case was in 1997, however a warning from the U.S. Food and Drug Administration was not released until 2011. Six years later, experts say awareness among doctors is low and most […]
Sheller hits #1 Top 50 Verdicts in Pennsylvania for 2016
Sheller PC’s $70 Million Risperdal win hits #1 on the Top 50 Verdicts in Pennsylvania in 2016. In the case A.Y., Pro Ami v. Janssen Pharmaceuticals, Inc., a jury found for an autistic Tennessee boy who grew female-like breasts after taking the antipsychotic drug Rispderal. The unprecedented $70 Million verdict in damages for physical disfigurement and emotional […]
High Court Won’t Hear Sheller Dispute with FDA over Risperdal
High Court Won’t Hear Dispute Challenging FDA Over J&J Drug Supreme Court won’t weigh in on whether law firm can sue FDA over drug labeling Circumstances in which third parties can sue over government actions remain unclear By Dana A. Elfin A Philadelphia-based law firm has hit the end of the road in its bid […]
Sheller discusses ‘Pharmageddon’ book on TV’s “America’s Lawyer”
“New Book Exposes Big Pharma’s Most Deceptive Marketing Practices” R-TV program “America’s Lawyer” featured host Mike Papantonio interviewing Stephen Sheller about his new book, Pharmageddon: A Nation Betrayed. The book covers significant cases Sheller has been involved with including Bush v. Gore ‘butterfly ballot’ issues, tobacco fraud cases and others. The main focus of the book is pharmaceutical […]
Texas Tribune Features Sheller Book Review
The Texas Tribune newspaper features Pharmageddon: A Nation Betrayed by Stephen A. Sheller and Sidney D. Kirkpatrick for the twice-monthly “Bookshelf” column. For the full Kirkus review, visit https://www.kirkusreviews.com/book-reviews/stephen-sheller/pharmageddon/
